ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,956Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 51

$502K Total Retail Price of All Prescriptions

Rank: 18 out of 51

551 Patients Receiving at Least One Drug in Part D
49%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

28% of this provider’s 551 patients filled at least one prescription for a schedule three drug, compared to an average of 27%.

Risky Drugs to Seniors

4% of this provider’s 9,079 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 936 558 1 5
HYDROCODONE-ACETAMINOPHEN 736 336 S3 2 1
SIMVASTATIN 636 439 3 4
QUINAPRIL HCL 487 268 10 4 152
HYDROCHLOROTHIAZIDE 453 283 5 15
CLONIDINE HCL 441 298 6 26
ATORVASTATIN CALCIUM 417 294 7 30
FUROSEMIDE 322 192 8 2
METFORMIN HCL 318 158 9 9
KLOR-CON 8 316 232 10 191
FELODIPINE ER 305 236 11 172
ALENDRONATE SODIUM 305 279 11 59
CARVEDILOL 302 192 13 13
LOSARTAN POTASSIUM 269 175 14 29
OMEPRAZOLE 250 161 15 3
RAMIPRIL 240 142 16 73
FAMOTIDINE 230 154 17 55
METFORMIN HCL ER 211 148 18 135
LEVOTHYROXINE SODIUM 192 138 19 6
ATENOLOL 188 78 20 33
LISINOPRIL 188 99 20 7
DOXAZOSIN MESYLATE 180 89 22 136
GLIMEPIRIDE 169 127 23 71
INSULIN SYRINGE 161 91 24 134
POTASSIUM CHLORIDE 142 100 25 8
CRESTOR 140 105 26 46
GLYBURIDE-METFORMIN HCL 132 109 R 27 242
HYDRALAZINE HCL 132 70 27 52
TRAMADOL HCL 128 53 29 10
ALLOPURINOL 127 59 30 43
LANTUS 126 58 31 31
METOPROLOL TARTRATE 123 64 32 14
LOVASTATIN 122 100 33 123
GABAPENTIN 118 36 34 12
GLIPIZIDE 109 47 35 40
TORSEMIDE 109 77 35 132
PRAVASTATIN SODIUM 106 59 37 19
BENAZEPRIL HCL 104 62 38 109
GLIPIZIDE ER 103 55 39 122
NOVOLIN 70-30 100 48 40 89
WARFARIN SODIUM 99 76 41 11
DONEPEZIL HCL 99 91 41 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 67 43 35
ISOSORBIDE MONONITRATE ER 92 75 44 57
AMITRIPTYLINE HCL 91 59 R 45 49
METOPROLOL SUCCINATE 91 81 45 25
VERAPAMIL ER 88 57 47 115
TRIAMTERENE-HCTZ 87 56 48 80
HYDROXYZINE HCL 87 51 R 48 99
IBUPROFEN 86 23 50 93
DIOVAN 78 61 51 70
METHOCARBAMOL 74 36 R 52 98
NAPROXEN 70 24 53 120
CLOPIDOGREL 70 33 53 41
LYRICA 68 18 55 54
CARISOPRODOL 63 19 R 56 116
LABETALOL HCL 63 38 56 231
PROAIR HFA 61 12 58 63
HUMULIN 70-30 61 27 58 104
RANITIDINE HCL 60 34 60 28
TRAZODONE HCL 59 30 61 23
LOSARTAN-HYDROCHLOROTHIAZIDE 56 27 62 66
AMILORIDE-HYDROCHLOROTHIAZIDE 54 33 63 302
PLAVIX 52 28 64 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.